Comportamiento de los costos hospitalarios en el sangrado digestivo alto no variceal

González Sosa, Gabriel; Pulido Barrientos, Osniel; Milián Valdés, Davel; Pérez Chávez, Pedro Julio.
Rev. cuba. cir ; 54(2)abr.-jun. 2015. tab
Artículo en Español | CUMED | ID: cum-61641

Documentos relacionados

  1. An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial.
  2. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
  3. Cost-Effectiveness Analysis of Transcatheter Arterial Embolization Techniques for the Treatment of Gastrointestinal Bleeding in the United States.
  4. Impaired activity of daily living is a risk factor for high medical cost in patients of non-variceal upper gastrointestinal bleeding.
  5. The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis.
  6. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
  7. Cost-Benefit Analysis of Using A Single Dose of Tranexamic Acid in Degenerative Lumbar Scoliosis Patients Undergoing Long-Segment Spinal Fusion Surgery: A Retrospective Study.
  8. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis.
  9. Pharmacologic Hemostatic Agents in Total Joint Arthroplasty-A Cost-Effectiveness Analysis.
  10. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012.